| Title |
Author |
Type |
Date |
Words |
| Critical Pathways Forward for Wet Age-Related Macular Degeneration in Asia-Pacific. |
|
|
May 7, 2013 |
445 |
| Advocating For Improved Treatment And Outcomes For Wet Age-Related Macular Degeneration In Australia. |
|
|
May 5, 2013 |
454 |
| Cholesterol tied to vision loss: lipid could be targeted in macular degeneration. |
Saey, Tina Hesman |
|
May 4, 2013 |
348 |
| With Early Detection and Proper Treatment, Millions of Americans Can Avoid Blindness Caused By Diabetic Retinopathy and Macular Degeneration. |
|
|
Apr 30, 2013 |
462 |
| Targeting cholesterol buildup in eye may help slow age-related vision loss. |
|
|
Apr 3, 2013 |
622 |
| Ophthalmologists Urge Early Diagnosis and Treatment of Age-Related Macular Degeneration. |
|
|
Apr 3, 2013 |
1303 |
| MD Stem Cells - Macular Degeneration Patient Continues to Improve Following Stem Cell Treatments. |
|
|
Mar 23, 2013 |
511 |
| Aspirin therapy may double risk of macular degeneration. |
Moon, Mary Ann |
|
Mar 1, 2013 |
563 |
| Oraya Therapy[TM] Continues to Show Efficacy for Wet Age-Related Macular Degeneration. |
|
|
Feb 28, 2013 |
1069 |
| MD Stem Cells: Very Elderly Benefit from Stem Cells for Macular Degeneration. |
|
|
Feb 21, 2013 |
788 |
| Research and Markets: Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2012. |
|
|
Feb 18, 2013 |
453 |
| Research and Markets: Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2012. |
|
|
Feb 7, 2013 |
384 |
| Research and Markets: Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2012. |
|
|
Feb 5, 2013 |
423 |
| Netherlands : Closing in on missing heritability and immune dysregulation in macular degeneration. |
|
|
Jan 17, 2013 |
355 |
| MD Stem Cells Improves Myopic Macular Degeneration with New Stem Cell Treatment. |
|
|
Jan 14, 2013 |
397 |
| FDA-Approved Telescope Implant Restores Sight To Those With Macular Degeneration. |
|
|
Jan 7, 2013 |
470 |
| Research and Markets: Age Related Macular Degeneration - Pipeline Review, H2 2012. |
|
|
Nov 28, 2012 |
379 |
| Germany : Bayer receives approval for EYLEA in Europe for the Treatment of Wet Age-Related Macular Degeneration. |
|
|
Nov 28, 2012 |
441 |
| EYLEA (aflibercept) Injection Approved for the Treatment of Wet Age-Related Macular Degeneration in Europe. |
|
|
Nov 27, 2012 |
2095 |
| Research and Markets: Global Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis - 2012. |
|
|
Nov 16, 2012 |
288 |
| Arctic Reaffirms the Value of Genetic Testing for Age-Related Macular Degeneration. |
|
|
Nov 15, 2012 |
999 |
| Macular degeneration treatment effective even in patients with other eye problem. |
|
|
Nov 12, 2012 |
251 |
| Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. |
|
Brief article |
Nov 1, 2012 |
242 |
| Macular Degeneration: National Seminar Series. |
|
|
Oct 28, 2012 |
356 |
| Research and Markets: Ophthalmology Therapeutics Market to 2018 - Dosing Convenience and Cost-Effectiveness Continue to Drive Eylea's Prescription Share in Wet Age-Related Macular Degeneration (Wet-AMD). |
|
|
Oct 25, 2012 |
519 |
| Ophthalmology Therapeutics Market to 2018 - Dosing Convenience and Cost-effectiveness Continue to Drive Eylea's Prescription Share in Wet Age-Related Macular Degeneration (Wet-AMD). |
|
|
Oct 22, 2012 |
3350 |
| Research and Markets: Macular Degeneration - Pipeline Review, H2 2012. |
|
|
Oct 2, 2012 |
438 |
| Macular degeneration; a patient's guide to treatment. |
|
Book review |
Oct 1, 2012 |
114 |
| Germany,Japan : EYLEA (aflibercept) Injection Approved for the Treatment of Wet Age-Related Macular Degeneration in Japan. |
|
|
Sep 29, 2012 |
451 |
| EYLEA (aflibercept) Injection Approved for the Treatment of Wet Age-Related Macular Degeneration in Japan. |
|
|
Sep 28, 2012 |
2211 |
| Ohr Pharmaceutical Initiates Phase II Trial of Squalamine Eye Drops For The Treatment Of Wet Macular Degeneration. |
|
|
Sep 24, 2012 |
1235 |
| Henry Grunwald's "Twilight: Losing Sight, Gaining Insight" Re-Launched During Age-Related Macular Degeneration (AMD) Week. |
|
|
Sep 24, 2012 |
460 |
| Germany : VEGF Trap-Eye (aflibercept ophthalmic injection) Recommended for Approval for the Treatment of Wet Age-Related Macular Degeneration in Europe. |
|
|
Sep 22, 2012 |
447 |
| EYLEA (aflibercept) Injection Recommended for Approval for the Treatment of Wet Age-Related Macular Degeneration in Europe. |
|
|
Sep 21, 2012 |
1912 |
| A simplified method of identifying the trained retinal locus for training in eccentric viewing. |
Vukicevic, Meri; Le, Anh; Baglin, James |
Clinical report |
Sep 1, 2012 |
3213 |
| Research and Markets: Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2012. |
|
|
Aug 21, 2012 |
419 |
| Research and Markets: Dry (Atrophic) Macular Degeneration - Pipeline Review, H1 2012. |
|
Report |
Aug 14, 2012 |
434 |
| Breakthrough in macular degeneration could prevent age-related blindness. |
|
|
Aug 7, 2012 |
371 |
| Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. |
|
Brief article |
Aug 1, 2012 |
253 |
| Retina Institute of Hawaii Participating in Allergan Investigational Drug Study for Wet Age-Related Macular Degeneration. |
|
Report |
Jul 11, 2012 |
476 |
| Research and Markets: Macular Degeneration - Pipeline Review, H1 2012. |
|
Report |
May 30, 2012 |
432 |
| Research and Markets: Age Related Macular Degeneration - Pipeline Review, H1 2012. |
|
|
May 23, 2012 |
411 |
| Free publication on living with macular degeneration. |
|
|
May 1, 2012 |
103 |
| Avastin and Lucentis are equivalent in treating age-related macular degeneration. |
|
|
Apr 30, 2012 |
121 |
| Cause of age-related macular degeneration revealed. |
|
|
Apr 27, 2012 |
271 |
| Lipotriad LLC Introduces New Vitamin with Proven Ingredients to Help Prevent Macular Degeneration. |
|
|
Mar 22, 2012 |
278 |
| Regeneron and Bayer Announce Approval of EYLEA[R] (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration in Australia. |
|
|
Mar 8, 2012 |
1868 |
| Genetic basis of age-related macular degeneration identified. |
|
|
Feb 24, 2012 |
398 |
| Macular Degeneration Specialists Introduce New Eye Vitamin Called Focus MaculaPro. |
|
|
Jan 31, 2012 |
960 |
| Grapes may help stave off age-related visual degeneration. |
|
|
Jan 13, 2012 |
388 |
| Research and Markets: Global Age-Related Macular Degeneration Drug Pipeline Capsule - 2012. |
|
|
Jan 11, 2012 |
436 |
| Book on coping with and treatments for age-related macular degeneration. |
|
Book review |
Jan 1, 2012 |
233 |
| Resource for people with macular degeneration. |
|
Book review |
Jan 1, 2012 |
190 |
| Regeneron and Bayer Initiate Phase 3 Clinical Program for the Treatment of Wet Age-Related Macular Degeneration in China. |
|
|
Nov 28, 2011 |
1845 |
| International AMD Expert Summit Convened in Berlin to Improve Treatment and Outcomes for Wet Age-Related Macular Degeneration. |
|
|
Nov 15, 2011 |
537 |
| Gene behind high risk of age-related macular degeneration identified. |
|
|
Oct 25, 2011 |
324 |
| Mayo Clinic Detective Work Shows Possible Side Effect in Macular Degeneration Drug. |
|
Clinical report |
Oct 24, 2011 |
639 |
| Three Hits in the Fight Against Age-Related Macular Degeneration. |
|
|
Oct 24, 2011 |
781 |
| Research and Markets: Macular Degeneration - Pipeline Review, H2 2011. |
|
|
Oct 11, 2011 |
421 |
| Research and Markets: Global Age-Related Macular Degeneration Drug Pipeline Capsule - 2011. |
|
|
Sep 29, 2011 |
370 |
| Research and Markets: Macular Degeneration Therapeutics - Pipeline Assessment and Market Forecasts to 2018. |
|
|
Sep 23, 2011 |
412 |
| Research and Markets: Macular Degeneration Global Clinical Trials Review, Q2, 2011. |
|
|
Sep 8, 2011 |
346 |
| Macular Degeneration Foundation Produces Video Explaining a Common Cause of Visual Hallucinations Among the Visually Impaired?. |
|
|
Aug 10, 2011 |
160 |
| Twin study explores factors that influence the course of macular degeneration. |
|
Brief article |
Aug 1, 2011 |
324 |
| New text on age-related macular degeneration. |
|
Brief review |
Aug 1, 2011 |
185 |
| Research and Markets: Age Related Macular Degeneration Pipeline Review, Q2 2011 - A Comprehensive Snapshot of the Global Therapeutic Scenario for Age Related Macular Degeneration. |
|
|
Aug 1, 2011 |
478 |
| Diet rich in vitamin D, nutrients cuts risk of macular degeneration in twins. |
|
|
Jul 6, 2011 |
321 |
| Higher vitamin D levels associated with reduced risk of macular degeneration among women. |
Dye, D. |
Brief article |
Jul 1, 2011 |
193 |
| EYLEA(TM) (aflibercept injection) Submitted in Japan for Marketing Authorization for the Treatment of Wet Age-Related Macular Degeneration. |
|
|
Jun 28, 2011 |
1658 |
| VEGF Trap-Eye Submitted for EU Marketing Authorization for Treatment of Wet Age-Related Macular Degeneration. |
|
|
Jun 7, 2011 |
1557 |
| Lawrence A. Yannuzzi, an authority in medical retinal diseases and pioneer in the treatment of age-related macular degeneration, recently received the 2010 Pisart Award from Lighthouse International, which includes a cash prize of $30,000. |
|
Brief article |
Jun 1, 2011 |
177 |
| Gene Therapy Shows Promise Against Age-Related Macular Degeneration. |
|
|
Apr 29, 2011 |
895 |
| NIH study finds Avastin and Lucentis are equally effective in treating age-related macular degeneration. |
|
|
Apr 28, 2011 |
115 |
| AMD Alliance Issues Global Call to Action to Improve Care of Patients with Wet Age-Related Macular Degeneration (AMD), a Leading Cause of Vision Loss in Developed World. |
|
|
Apr 14, 2011 |
644 |
| Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina. |
Dasari, Bhanu; Prasanthi R.P., Jaya; Marwarha, Gurdeep; Singh, Brij B.; Ghribi, Othman |
|
Apr 1, 2011 |
379 |
| Intraocular telescopes for macular degeneration: course code C-15909 O/D. |
Moriarty, Brendan J. |
Report |
Mar 25, 2011 |
2509 |
| Stem cell therapy for age-related macular degeneration may soon be a reality. |
|
|
Mar 25, 2011 |
492 |
| Greater omega-3 fatty acid intake associated with protection against advanced age-related macular degeneration. |
Dye, D |
Brief article |
Mar 1, 2011 |
203 |
| The societal impact of age-related macular degeneration: use of social support resources differs by the severity of the impairment. |
Brennan, Mark; Horowitz, Amy; Reinhardt, Joann P.; Stuen, Cynthia; Rubio, Roman; Oestreicher, Nina |
Report |
Jan 1, 2011 |
7146 |
| Participants needed for age-related macular degeneration study. |
|
|
Jan 1, 2011 |
232 |
| ScienceBased Health Announces the Launch of Next-Generation Nutritional Formulations for Age-Related Macular Degeneration. |
|
|
Nov 30, 2010 |
604 |
| Bayer and Regeneron Report Positive Top-Line Results of Two Phase 3 Studies with VEGF Trap-Eye in Wet Age-related Macular Degeneration. |
|
|
Nov 22, 2010 |
2902 |
| Regeneron Schedules November 22, 2010 Teleconference and Webcast to Discuss Results of Two Phase 3 Studies with VEGF Trap-Eye in Wet Age-related Macular Degeneration. |
|
|
Nov 19, 2010 |
501 |
| Adult stem cells show promise in treating age-related macular degeneration and retinitis pigmentosa (09/17/10). |
|
|
Oct 1, 2010 |
227 |
| AMD Week 2010 Unites Organizations Around the World to Raise Awareness of Age Related Macular Degeneration (AMD). |
|
|
Sep 17, 2010 |
958 |
| Living With Macular Degeneration. |
|
|
Sep 10, 2010 |
222 |
| Research and Markets: Macular Degeneration Therapy Area Pipeline Report: Detailed Product Descriptions, Information on Partnering Activity Plus Clinical Trial Intelligence. |
|
Report |
Jul 6, 2010 |
434 |
| Iron overload may be linked to macular degeneration. |
|
|
Jun 25, 2010 |
209 |
| Diets high in fat increase risk of macular degeneration. |
Ellman, Marc |
Brief article |
Jun 1, 2010 |
241 |
| Additional genes linked to age-related macular degeneration identified. |
|
|
Apr 13, 2010 |
429 |
| Additional Genes Associated with Age-Related Macular Degeneration Identified. |
|
|
Apr 12, 2010 |
125 |
| Paloma Pharmaceuticals Receives Approval to Enter Phase I Clinical Trials; - IND Accepted by FDA to Initiate Intravitreal and Subconjunctival Administration of Palomid 529 in Age-Related Macular Degeneration Patients -. |
|
|
Feb 4, 2010 |
775 |
| Smoking 'worsens age-related macular degeneration'. |
|
|
Dec 31, 2009 |
375 |
| ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD). |
|
|
Dec 11, 2009 |
902 |
| Changes in the posterior segment with age. |
Gurbaxani, Avi; Hammond, Chris |
Report |
Nov 20, 2009 |
5679 |
| Regular egg-yolk consumption may reduce the risk of dry, age-related macular degeneration by raising macular pigment concentrations, according to a report in the November issue of the American Journal of Clinical Nutrition. |
|
|
Nov 16, 2009 |
319 |
| Cataract surgery doesn't worsen age-related macular degeneration. |
|
|
Nov 10, 2009 |
462 |
| Omega 3 oils could help cut age-related macular degeneration risk. |
|
|
Jul 23, 2009 |
179 |
| New laser technique may delay onset of age-related macular degeneration. |
|
|
Jul 6, 2009 |
282 |
| Salmona, tuna 'protects against age-related macular degeneration'. |
|
|
Jun 19, 2009 |
365 |
| New target for diagnosis, treatment of age-related macular degeneration identified. |
|
|
Jun 15, 2009 |
422 |
| Eating oily fish may benefit people with age-related macular degeneration. |
|
|
Jun 9, 2009 |
422 |
| Low cognitive function linked to age-related macular degeneration. |
|
|
May 12, 2009 |
300 |
| Omega-3 fatty acids, low glycemic index diet protects against age-related macular degeneration. |
|
|
May 3, 2009 |
239 |
| Research and Markets: Competitor Analysis: Wet Age-Related Macular Degeneration (AMD). |
|
|
Feb 25, 2009 |
313 |
| Cataract Surgery and Macular Degeneration; Beauty in the Eye of the Beholder; Are Genes or Environmental Factors to Blame for Poorer Vision as We Age? |
|
|
Feb 2, 2009 |
1671 |
| Retinal cell regeneration in mice offers macular degeneration treatment hope. |
|
|
Dec 3, 2008 |
700 |
| Retinal cell regeneration in mice offers macular degeneration treatment hope. |
|
|
Nov 25, 2008 |
700 |
| Glycemic Control Appears to Reduce Type 1 Diabetics' Retinopathy Risk; Night Vision Symptoms May Predict Macular Degeneration Progression. |
|
|
Nov 3, 2008 |
946 |
| VEGF Trap-Eye Final Phase 2 Results in Age-related Macular Degeneration Presented at 2008 Retina Society Meeting. |
|
|
Sep 28, 2008 |
1735 |
| Acucela and Otsuka Pharmaceutical Enter Co-Development Agreement for ACU-4429 in Dry Age Related Macular Degeneration. |
|
|
Sep 4, 2008 |
839 |
| Presentations on the Mechanism of Action of VEGFb(TM), the World's only "Triple Action Angiogenesis Modulator," Support VEGFb's Role as a Promising Treatment for Solid Cancers, Macular Degeneration, and Other Diseases. |
|
|
Sep 2, 2008 |
1110 |
| Regeneron and Bayer HealthCare Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-Related Macular Degeneration. |
|
|
Aug 19, 2008 |
1393 |
| Macular Degeneration Risk Studied in an Asian Population; Time Spent Outdoors Impacts Nearsightedness in Children; and Two Treatments to Combat Ocular Surface Cancer. |
|
|
Aug 1, 2008 |
1145 |
| Retina Group of New York To Present Seminar on Age-Related Macular Degeneration. |
|
|
Jul 25, 2008 |
543 |
| Alcon Terminates the Development of Anecortave Acetate in Age-Related Macular Degeneration. |
|
|
Jul 11, 2008 |
393 |
| Estrogen exposures had mixed role in age-related macular degeneration risk. |
Lesney, Mark S. |
|
May 1, 2008 |
468 |
| Regeneron and Bayer HealthCare Announce Encouraging 32-Week Follow-Up Results from a Phase 2 Study of VEGF Trap-Eye in Age-Related Macular Degeneration. |
|
|
Apr 28, 2008 |
1736 |
| PhiloGene Inc. Announces Revolutionary Advances in the Treatment of Cancer and Macular Degeneration. |
|
|
Apr 22, 2008 |
974 |
| Journal Highlights New Findings on Age-Related Macular Degeneration and Nutrition, Eye Injuries in the Iraq War, and Quality of Life for Glaucoma Patients. |
|
|
Feb 1, 2008 |
823 |
| New hope from eye surgery; Fashion & health Mr Teifi James is the first eye surgeon in Yorkshire to perform a revolutionary new treatment for dry macular degeneration - a disabling condition that affects many elderly people. The operation is now being offered to patients at the Elland Hospital. |
|
|
Dec 27, 2007 |
700 |
| Pittsburgh Based Associates in Ophthalmology Announces New Treatments for Patients Suffering from Macular Degeneration. |
|
|
Oct 30, 2007 |
345 |
| Regeneron Announces Positive Primary Endpoint Results from a Phase 2 Study of VEGF Trap-Eye in Age-related Macular Degeneration. |
|
|
Oct 1, 2007 |
1410 |
| lifestyle: What is Macular Degeneration? |
|
|
Aug 11, 2007 |
313 |
| Regeneron and Bayer HealthCare Initiate Phase 3 Global Development Program For VEGF Trap-Eye In Wet Age-Related Macular Degeneration (AMD). |
|
|
Aug 3, 2007 |
1450 |
| Insight into the Pipeline Status of Macular Degeneration Drugs. |
|
|
Jul 13, 2007 |
303 |
| Looking into our eyes: if you're approaching 50, you should know about macular degeneration. |
Byron, Su |
|
Jun 22, 2007 |
1596 |
| OXiGENE Announces a Poster Presentation Highlighting Results from its Study of ZYBRETSTAT(TM) CA4P in Myopic Macular Degeneration (Study MMD-213) at the 47th Annual Meeting of the Association of Research in Vision and Ophthalmology. |
|
|
May 7, 2007 |
586 |
| Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration. |
|
Clinical report |
Mar 27, 2007 |
1331 |
| Potentia Pharmaceuticals Announces Initiation of Phase I Clinical Trials to Evaluate its Lead Compound for Age-Related Macular Degeneration. |
|
|
Mar 20, 2007 |
872 |
| OXiGENE Announces Positive Results from its Phase II CA4P Clinical Trial in Myopic Macular Degeneration (MMD-213). |
|
|
Feb 15, 2007 |
695 |
| Good news for "wet" macular degeneration. |
|
|
Jan 1, 2007 |
280 |
| How potatoes and cookies can cause macular degeneration. |
|
|
Dec 1, 2006 |
1228 |
| 'Don't Lose Sight' National Campaign Aims to Educate Americans about Macular Degeneration. |
|
|
Nov 2, 2006 |
867 |
| New Treatment Significantly Improves Vision in Patients With Wet Age-Related Macular Degeneration - The Leading Cause of Blindness in the UK. |
|
|
Oct 4, 2006 |
1840 |
| OXiGENE to Focus Ophthalmology Strategy Toward Non-Invasive Administration of CA4P for Age-Related Macular Degeneration (AMD); Closes Enrollment of Phase II CA4P Clinical Trial in Myopic Macular Degeneration (MMD-213). |
|
|
Sep 12, 2006 |
802 |
| Biologic treatment for wet age-related macular degeneration approved by FDA. |
|
|
Aug 1, 2006 |
307 |
| OSI Pharmaceuticals and Pfizer Announce Phase IV Macugen(R)(pegaptanib sodium injection) Maintenance Trial in Neovascular Age-Related Macular Degeneration (AMD). |
|
|
Jun 26, 2006 |
1694 |
| Regeneron Reports Positive Phase 1 Data for the VEGF Trap in Age-Related Macular Degeneration; Preliminary Results Show Improvements in Vision and Retinal Swelling; VEGF Trap Was Well Tolerated at All Dose Levels. |
|
|
May 1, 2006 |
1238 |
| Macular degeneration. |
SerVaas, Cory |
Brief article |
May 1, 2006 |
260 |
| This common food can protect you from inflammation, heart disease, diabetes, and macular degeneration. |
Fuchs, Nan Kathryn |
|
May 1, 2006 |
1318 |
| Othera Pharmaceuticals and the National Eye Institute Collaborate in Dry AMD Study; A Phase II Study of OT-551 Antioxidant Eye Drop in Participants with Bilateral Geographic Atrophy Associated with Age-Related Macular Degeneration. |
|
|
Apr 5, 2006 |
387 |
| Statin use and macular degeneration. |
|
|
Mar 1, 2006 |
203 |
| Regeneron's VEGF Trap Demonstrates Positive Preliminary Results in Patients with Age-Related Macular Degeneration; Phase 1 Preliminary Results to Be Presented at the Angiogenesis 2006 Meeting Sponsored by Bascom Palmer Eye Institute. |
|
|
Feb 2, 2006 |
677 |
| Clinical Trial on Gene Therapy for Macular Degeneration Published in Human Gene Therapy. |
|
|
Jan 17, 2006 |
597 |
| Macular Degeneration; Treatment. |
|
|
Dec 16, 2005 |
1676 |
| Macular Degeneration; Key Q&A. |
|
|
Dec 16, 2005 |
1888 |
| Genaera Presents Positive Preliminary Clinical Results for EVIZON(TM) for Treatment of Age-Related Macular Degeneration at the Annual AAO Meeting. |
|
|
Oct 19, 2005 |
1780 |
| Genaera Announces Preliminary Phase II Data Showing EVIZON(TM) With Visudyne(R) Demonstrate Safety and Stabilization of Vision in Wet Age-Related Macular Degeneration. |
|
|
Oct 11, 2005 |
1710 |
| Pharmacopeia forms macular degeneration agreement with Allergan. |
|
|
Jun 1, 2005 |
370 |
| Macular Degeneration; Overview. |
|
|
Apr 22, 2005 |
1464 |
| Macular Degeneration; Treatment. |
|
|
Mar 16, 2005 |
1773 |
| Macular Degeneration; Key Q&A. |
|
|
Mar 16, 2005 |
1987 |
| Macular degeneration could be slowed with lutein. |
|
|
Mar 22, 2004 |
235 |
